Literature DB >> 7705181

Computer image analysis of comparative genomic hybridization.

J Piper1, D Rutovitz, D Sudar, A Kallioniemi, O P Kallioniemi, F M Waldman, J W Gray, D Pinkel.   

Abstract

We describe and evaluate the image-processing and analysis techniques we have developed for the quantitative analysis of comparative genomic hybridization (CGH; Science 258:818, 1992). In a typical CGH application, two genomic DNA samples are simultaneously hybridized to metaphase chromosomes and detected with different fluorochromes. The primary data in CGH are contained in the intensity ratios of the fluorochromes as a function of position on the chromosomes, which reflect variation in DNA copy number ratio between the two DNA samples. Analysis involves chromosome segmentation, intensity normalization, background corrections, and calculation of the fluorescence intensity profiles and the ratio profile along the chromosome's length. Profiles from several copies of the same chromosome in different metaphases are averaged to reduce the noise. Confidence intervals are calculated and displayed for the mean profiles. The techniques were evaluated by examining the variability found in comparisons of two normal genomic DNAs, where the ratio was expected to be constant, and by measuring the ratios obtained for cell lines with cytogenetically documented copy number changes involving several chromosomal segments. The limits of sensitivity of CGH analysis were investigated by simulation. Guidelines for the interpretation of CGH data and indications of areas for future development of the analytical techniques are also presented.

Mesh:

Year:  1995        PMID: 7705181     DOI: 10.1002/cyto.990190104

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  28 in total

Review 1.  Comparative genomic hybridisation.

Authors:  M M Weiss; M A Hermsen; G A Meijer; N C van Grieken; J P Baak; E J Kuipers; P J van Diest
Journal:  Mol Pathol       Date:  1999-10

Review 2.  The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management.

Authors:  W King; J Proffitt; L Morrison; J Piper; D Lane; S Seelig
Journal:  Mol Diagn       Date:  2000-12

3.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae.

Authors:  Stephanie Smith; Ji-Young Hwang; Soma Banerjee; Anju Majeed; Amitabha Gupta; Kyungjaem Myung
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

5.  Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival.

Authors:  A N Jain; K Chin; A L Børresen-Dale; B K Erikstein; P Eynstein Lonning; R Kaaresen; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 6.  Advances in cytogenetic analysis of solid tumours.

Authors:  L James; J Varley
Journal:  Chromosome Res       Date:  1996-11       Impact factor: 5.239

7.  Mosaic supernumerary ring chromosome 19 identified by comparative genomic hybridisation.

Authors:  S R Ghaffari; E Boyd; J M Connor; A M Jones; J L Tolmie
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

8.  Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

Authors:  T Kuukasjärvi; M Tanner; S Pennanen; R Karhu; O P Kallioniemi; J Isola
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

9.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

Authors:  Y Hirose; K Aldape; A Bollen; C D James; D Brat; K Lamborn; M Berger; B G Feuerstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

10.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.